Table 1. Candidate genes and candidate epistatic variants.
| Gene | ID | Effect | Proposed Interaction | Reference |
|---|---|---|---|---|
| APOA1 | rs670 | Deleterious | Buffered | Garasto et al., 2003 [45] |
| APOE | APOEε4 | Deleterious | APOEε4 buffered by HP1/1 | Napolioni et al., 2011 [44] |
| HFE | rs1800562 | Deleterious | HFE T allele buffered | Tan et al., 2003 [24] |
| KL | rs9536314 | Deleterious | KL het buffered | Bergman et al., 2007 [7] |
| LPA(1) | rs1853021 | Deleterious | LPA het buffered by CETP VV | Bergman et al., 2007 [7] |
| LPA(2) | rs3798220 | Deleterious | Risk for coronary disease | Clarke et al., 2009 [22] |
| LPA(3) | rs10455872 | Deleterious | Risk for coronary disease | Clarke et al., 2009 [22] |
| MTTP | rs2866164 | Deleterious | MTTP CC buffered by APOC3 CC, CETP VV, ADIPOQ del/del | Huffman et al., 2012 [46] |
| PON1 | rs662 | Deleterious | PON1 het buffered | Bonafè et al., 2002 [47] |
| ADIPOQ | rs56354395 | Protective | ADIPOQ del/del buffers MTTP CC | Atzmon et al., 2008 [27] |
| APOC3 | rs595049 (LD with rs2542052) | Protective | APOC3 CC buffers MTTP CC | Atzmon et al., 2006 [48] |
| CETP | rs5882 | Protective | CETP VV buffers MTTP CC, LPA(1) het | Barzilai et al., 2003 [29] |
| CRYL1 | rs7989332 | Protective | AD-associated with KHDRBS2 | Gusareva et al., 2014 [15] |
| FOXO1 | rs2701858 | Protective | Joint effect with FOXO3(1) for longevity | Tan et al., 2013 [49] |
| FOXO3(1) | rs9486902 | Protective | Joint effect with FOXO1 for longevity | Tan et al., 2013 [49] |
| FOXO3(2) | rs2802292 | Protective | FOXO3 GG buffering | Willcox et al., 2008 [20] |
| HP | rs72294371 | Protective | HP1/1 buffers APOEε4 | Napolioni et al., 2011 [44] |
| KHDRBS2 | rs6455128 | Protective | AD-associated with CRYL1 | Gusareva et al., 2014 [15] |
Effect indicates whether the variant was considered be deleterious or protective in the original literature report. Het = heterozygous, AD = Alzheimer's disease.